IDEX BIOMETRICS ASA
The board of directors of IDEX Biometrics ASA resolved on 24 February 2021 to issue 934,900 incentive subscription rights to employees in the IDEX group. The grant was made under the company's 2020 incentive subscription rights plan as resolved at the annual general meeting on 15 May 2020. The exercise price of the subscription rights is NOK 3.10 per share. The subscription rights vest by 25% per year over four years and expire on 15 May 2025. Following the grant there are 57,278,993 subscription rights outstanding in IDEX.
For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 9180 0186
Derek D’Antilio, Chief Financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 978 273 1344
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow on Twitter @IDEXBiometrics
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CoinShares International Limited24.10.2025 17:00:00 CEST | Press release
CoinShares Announces Change to Financial Calendar as Part of its US Transaction
Biogen Inc.24.10.2025 13:30:44 CEST | Press release
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
The Government of Gangnan District, Guigang City24.10.2025 13:06:07 CEST | Press release
Gangnan District, Guigang City, Guangxi: Building a Wood-Based Smart Home Industry Cluster Facing ASEAN
Ress Life Investments A/S24.10.2025 10:58:13 CEST | Press release
Ress Life Investments A/S, Decisions of the extraordinary general meeting held on 24 October 2025
Sveriges Riksbank24.10.2025 10:07:39 CEST | Press release
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
